| KSDVX | VSCAX | KSDVX / VSCAX | |
| Total Expense Ratio | 1.29 | 1.10 | 117% |
| Annual Report Gross Expense Ratio | 1.50 | 1.10 | 136% |
| Fund Existence | 16 years | 27 years | - |
| Gain YTD | 4.935 | 7.230 | 68% |
| Front Load | 5% | 6% | 82% |
| Min. Initial Investment | 2500 | 1000 | 250% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 267M | 8.84B | 3% |
| Annual Yield % from dividends | 1.29 | 0.25 | 511% |
| Returns for 1 year | 8.90 | 13.42 | 66% |
| Returns for 3 years | 14.68 | 49.33 | 30% |
| Returns for 5 years | 4.97 | 60.33 | 8% |
| Returns for 10 years | 53.38 | 99.03 | 54% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HLGEX | 51.49 | 0.09 | +0.18% |
| JPMorgan Mid Cap Growth I | |||
| DUSQX | 38.06 | -0.07 | -0.18% |
| DFA US Large Cap Equity Institutional | |||
| ERHSX | 14.83 | -0.03 | -0.20% |
| Eaton Vance Worldwide Health Sci R | |||
| DESSX | 26.30 | -0.06 | -0.23% |
| DWS Enhanced Core Equity S | |||
| PQDMX | 17.29 | -0.08 | -0.46% |
| PGIM Quant Solutions Intl Dev Mkts IdxR6 | |||